Development and validation of disease-specific measures for choroidal melanoma: COMS-QOLS report no. 2

Archives of Ophthalmology

Volumn 121, Issue 7, 2003, Pages 1010-1020

  Melia, Michele ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125;

ADULT; AGED; ANXIETY; ARTICLE; BINOCULAR VISION; BRACHYTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CHOROID MELANOMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; ENUCLEATION; EVALUATION; FEMALE; HEALTH SURVEY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MENTAL HEALTH; MULTICENTER STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; SCORING SYSTEM; STEREOSCOPIC VISION; TUMOR VOLUME; VALIDATION PROCESS; VISUAL ACUITY; VISUAL DISORDER;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CHOROID NEOPLASMS; CROSS-SECTIONAL STUDIES; DEPTH PERCEPTION; EYE ENUCLEATION; FEMALE; HEALTH STATUS; HUMANS; IODINE RADIOISOTOPES; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; VISION DISORDERS; VISION, BINOCULAR;

EID: 0038601907     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.121.7.1010     Document Type: Article

References (39)

1. Rose K, Harper R, Tromans C, et al. Quality of life in myopia. Br J Ophthalmol. 2000;84:1031-1034.
2. Brahma A, Ennis F, Harper R, Ridgway A, Tullo A. Visual function after penetrating keratoplasty for keratoconus: a prospective longitudinal evaluation. Br J Ophthalmol. 2000;84:60-66.
3. Brody BL, Gamst AC, Williams RA, et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology. 2001;108:1893-1901.
4. Schiffman RM, Jacobsen G, Whitcup SM. Visual functioning and general health status in patients with uveitis. Arch Ophthalmol. 2001;119:841-849.
5. Klein R, Moss SE, Klein BEK, Gutierrez P, Mangione CM. The NEI-VFQ-25 in people with long-term type 1 diabetes mellitus: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol. 2001;119:733-740.
6. Lau J, Michon JJ, Chan W-S, Ellwein LB. Visual acuity and quality of life outcomes in cataract surgery patients in Hong Kong. Br J Ophthalmol. 2002;86:12-17.
7. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. Arch Ophthalmol. 1996;114:23-33.
8. Cole SR, Beck RW, Moke PS, Gal RL, Long DT, the Optic Neuritis Study Group. The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Invest Ophthalmol Vis Sci, 2000;41:1017-1021.
9. Janz NK, Wren PA, Lichter PR, et al. The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology. 2001;108:1954-1965.
10. Drummond MF, ed. Measuring the Quality of Life of People with Visual Impairment. Proceedings of a Workshop. Washington, DC: US Dept of Health and Human Services; 1990. NIH publication No. 90-3078.
11. Collaborative Ocular Melanoma Study Group. Design and methods of a clinical trial for a rare condition: the Collaborative Ocular Melanoma Study: COMS Report No. 3. Control Clin Trials. 1993;14:362-391.
12. Collaborative Ocular Melanoma Study. COMS Manual of Procedures. Springfield, Va: National Technical Information Service; 1995. NTIS accession No. PB95-179693.
13. COMS Quality of Life Study Group. Quality of life assessment in the Collaborative Ocular Melanoma Study: design and methods: COMS-QOLS Report No. 1. Ophthalmic Epidemiol. 1999;6:5-17.
14. The Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings: COMS Report No. 18. Arch Ophthalmol. 2001;119:969-982.
15. Stewart AL, Hays RD, Ware JE. The MOS Short-Form General Health Survey. Med Care. 1988;26:724-735.
16. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): conceptual framework and item selection. Med Care. 1992;30:473-483.
17. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, Mass: Health Institute, New England Medical Center; 1993.
18. Mangione CM, Phillips RS, Seddon JM, et al. Development of the "Activities of Daily Vision Scale": a measure of visual functional status. Med Care. 1992;30:1111-1126.
19. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD, for the National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050-1058.
20. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361-370.
21. Holmes S. Preliminary investigations of symptom distress in two cancer patient populations: evaluation of a measurement instrument. J Adv Nurs. 1991;16:439-446.
22. Bliss JM, Selby PJ, Robertson B, Powles TJ. A method for assessing the quality of life of cancer patients: replication of the factor structure. Br J Cancer. 1992;65:961-966.
23. Eiser C, Havermans T, Craft A, Kernahan J. Development of a measure to assess the perceived illness experience after treatment for cancer. Arch Dis Child. 1995;72:302-307.
24. McQuellon RP, Craven B, Russell GB, et al. Quality of life in breast cancer patients before and after autologous bone marrow transplantation. Bone Marrow Transplant, 1996;18:579-594.
25. Hodder SC, Edwards MJ, Brickely MR, Shepherd JP. Multiattribute utility assessment of outcomes of treatment for head and neck cancer. Br J Cancer. 1997;75:898-902.
26. Ness RM, Holmes A, Klein, R, Greene J, Dittus R. Outcome states of colorectal cancer: identification and description using patient focus groups. Am J Gastroenterol. 1998;93:1491-1497.
27. Northouse LL, Schafer JA, Tipton J, Metivier L. The concerns of patients and spouses after the diagnosis of colon cancer: a qualitative analysis. J Wound Ostomy Continence Nurs. 1999;26:8-17.
28. List MA, Stracks J, Colangelo L, et al. How do head and neck cancer patients prioritize treatment outcomes before initiating treatment? J Clin Oncol. 2000;18:877-884.
29. Fukuda K, Saeki N, Mine S, et al. Evaluation of outcome and QOL in patients with craniofacial resection for malignant tumors involving the anterior skull base. Neurol Res. 2000;22:545-550.
30. Hopwood P, Fletcher I, Lee A, Al Ghazal S. A body image scale for use with cancer patients. Eur J Cancer. 2001;37:189-197.
31. Harris DL, Carr AT. The Derriford Appearance Scale (DAS59): a new psychometric scale for the evaluation of patients with disfigurements and aesthetic problems of appearance. Br J Plast Surg. 2001;54:216-222.
32. Hays RD, Hayashi T, Beyond internal consistency reliability: rationale and user's guide for multitrait scaling program on the microcomputer. Behav Res Methods Instrum Comput. 1990;22:167-175.
33. Hays RD, Wang E, Multitrait scaling program: MULTI. In: Proceedings of the Seventeenth Annual SAS Users Group International Conference. Cary, NC: SAS Institute Inc; 1992:1151-1156.
34. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika, 1951;16:297-334.
35. The theory of measurement error. In: Nunnally JC. Psychometric Theory. New York, NY: McGraw-Hill Co; 1978:190-255.
36. Gliklich RE, Goldsmith TA, Funk GF. Are head and neck specific quality of life measures necessary? Head Neck. 1997;19:474-480.
37. Bessette L, Sangha O, Kuntz KM, et al. Comparative responsiveness of generic versus disease-specific and weighted versus unweighted health status measures in carpal tunnel syndrome. Med Care. 1998;36:491-502.
38. Guyatt GH, King DR, Feeny DH, Stubbing D, Goldstein RS. Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. J Clin Epidemiol. 1999;52:187-192.
39. Janni W, Rjosk D, Dimpfl TH, et al. Quality of life influenced by primary surgical treatment for stage I-III breast cancer: long-term follow-up of a matched-pair analysis. Ann Surg Oncol. 2001;8:542-548.